Literature DB >> 12351703

Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.

Behzad Banihashemi1, Paul R Albert.   

Abstract

The G protein specificity of multiple signaling pathways of the dopamine-D2S (short form) receptor was investigated in GH4ZR7 lactotroph cells. Activation of the dopamine-D2S receptor inhibited forskolin-induced cAMP production, reduced BayK8644- activated calcium influx, and blocked TRH-mediated p42/p44 MAPK phosphorylation. These actions were blocked by pretreatment with pertussis toxin (PTX), indicating mediation by G(i/o) proteins. D2S stimulation also decreased TRH-induced MAPK/ERK kinase phosphorylation. TRH induced c-Raf but not B-Raf activation, and the D2S receptor inhibited both TRH-induced c-Raf and basal B-Raf kinase activity. After PTX treatment, D2S receptor signaling was rescued in cells stably transfected with individual PTX-insensitive Galpha mutants. Inhibition of adenylyl cyclase was partly rescued by Galpha(i)2 or Galpha(i)3, but Galpha(o) alone completely reconstituted D2S-mediated inhibition of BayK8644-induced L-type calcium channel activation. Galpha(o) and Galpha(i)3 were the main components involved in D2S-mediated p42/44 MAPK inhibition. In cells transfected with the carboxyl-terminal domain of G protein receptor kinase to inhibit Gbetagamma signaling, only D2S-mediated inhibition of calcium influx was blocked, but not inhibition of adenylyl cyclase or MAPK. These results indicate that the dopamine-D2S receptor couples to distinct G(i/o) proteins, depending on the pathway addressed, and suggest a novel Galpha(i)3/Galpha(o)-dependent inhibition of MAPK mediated by c-Raf and B-Raf-dependent inhibition of MAPK/ERK kinase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351703     DOI: 10.1210/me.2001-0220

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  14 in total

1.  Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype.

Authors:  Allyson Booth; Tammy Trudeau; Crystal Gomez; M Scott Lucia; Arthur Gutierrez-Hartmann
Journal:  Mol Endocrinol       Date:  2014-12

2.  Region-specific regulation of 5-HT1A receptor expression by Pet-1-dependent mechanisms in vivo.

Authors:  Kirsten X Jacobsen; Margaret Czesak; Mariam Deria; Brice Le François; Paul R Albert
Journal:  J Neurochem       Date:  2011-01-24       Impact factor: 5.372

3.  Molecular cloning and characterization of crustacean type-one dopamine receptors: D1alphaPan and D1betaPan.

Authors:  Merry C Clark; Deborah J Baro
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2006-01-19       Impact factor: 2.231

4.  Arthropod D2 receptors positively couple with cAMP through the Gi/o protein family.

Authors:  Merry C Clark; Deborah J Baro
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2006-10-10       Impact factor: 2.231

5.  TNFAIP8: a new effector for Galpha(i) coupling to reduce cell death and induce cell transformation.

Authors:  Benoit Laliberté; Ariel M Wilson; Houman Nafisi; Helen Mao; Yi Yuen Zhou; Mireille Daigle; Paul R Albert
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

6.  Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells).

Authors:  Guihua Cao; Alice Gardner; Thomas C Westfall
Journal:  Biochem Pharmacol       Date:  2007-01-07       Impact factor: 5.858

7.  Each individual isoform of the dopamine D2 receptor protects from lactotroph hyperplasia.

Authors:  Daniela Radl; Claudia De Mei; Eric Chen; Hyuna Lee; Emiliana Borrelli
Journal:  Mol Endocrinol       Date:  2013-04-22

8.  RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway.

Authors:  Michael A James; Yan Lu; Yan Liu; Haris G Vikis; Ming You
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

9.  Arachidonic acid inhibition of L-type calcium (CaV1.3b) channels varies with accessory CaVbeta subunits.

Authors:  Mandy L Roberts-Crowley; Ann R Rittenhouse
Journal:  J Gen Physiol       Date:  2009-04       Impact factor: 4.086

10.  Integrated multi-omics profiling of nonfunctioning pituitary adenomas.

Authors:  Zhenqing Wei; Cuiqi Zhou; Minghui Li; Ruocheng Huang; Hongjuan Deng; Stephen Shen; Renzhi Wang
Journal:  Pituitary       Date:  2020-11-18       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.